Φορτώνει......
Theranostics in immuno-oncology using nanobody derivatives
Targeted therapy and immunotherapy have become mainstream in cancer treatment. However, only patient subsets benefit from these expensive therapies, and often responses are short‐lived or coincide with side effects. A growing modality in precision oncology is the development of theranostics, as this...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Theranostics |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Ivyspring International Publisher
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6831473/ https://ncbi.nlm.nih.gov/pubmed/31695800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.34941 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|